Preoperative paroxysmal atrial fibrillation predicts high cardiovascular mortality in patients undergoing surgical aortic valve replacement with a bioprosthesis: CAREAVR study.
Maunu NissinenJoonas LehtoFausto BiancariTuomo NieminenMarkus MalmbergFredrik YannopoulosSamuli SalmiKari Eino Juhani AiraksinenTuomas O KiviniemiJuha E K HartikainenPublished in: Clinical cardiology (2020)
Patients undergoing SAVR with bioprosthesis and history of paroxysmal AF had higher risk of developing permanent AF, cardiovascular mortality and incidence of fatal strokes compared to patients with preoperative sinus rhythm. Life-long anticoagulation should be considered in patients with a history of preoperative paroxysmal AF.
Keyphrases
- atrial fibrillation
- patients undergoing
- aortic valve replacement
- transcatheter aortic valve implantation
- aortic valve
- catheter ablation
- aortic stenosis
- left atrial
- oral anticoagulants
- left atrial appendage
- risk factors
- direct oral anticoagulants
- cardiovascular events
- heart failure
- transcatheter aortic valve replacement
- percutaneous coronary intervention
- ejection fraction
- left ventricular
- venous thromboembolism